1 | 49986 | [Inhibition of viral reverse transcriptase and leukemogenesis by modified nucleic acids (author's transl)]. | Z Krebsforsch Klin Onkol Cancer Res Clin Oncol | 1975 |
1 |
2 | 2168225 | Sulfation of tyrosine residues in coagulation factor V. | Blood | 1990 Sep 1 |
3 |
3 | 2236295 | Fractionation and characterization of mitogenic and anti-complementary active fractions from kampo (Japanese Herbal) medicine "juzen-taiho-to". | Planta Med | 1990 Aug |
2 |
4 | 3944265 | Isolation and study of an acquired inhibitor of human coagulation factor V. | J Clin Invest | 1986 Feb |
2 |
5 | 4015398 | Phthalates and organophosphorus compounds as cholinesterase inhibitors in fractions of industrial hexane impurities. | Arch Toxicol | 1985 Apr |
1 |
6 | 7076681 | Thrombin-catalyzed activation of human coagulation factor V. | J Biol Chem | 1982 Jun 10 |
2 |
7 | 7631299 | Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene. | Thromb Res | 1995 May 1 |
1 |
8 | 7653875 | [Optimization of artificial pulmonary ventilation in patients with organophosphorus compound poisoning complicated by development of exotoxic shock]. | Anesteziol Reanimatol | 1995 May-Jun |
1 |
9 | 8571340 | APC-resistance and Mnl I genotype (Gln 506) of coagulation factor V are rare in Japanese population. | Thromb Haemost | 1995 Sep |
1 |
10 | 8589213 | No association of APC resistance with myocardial infarction. | Blood Coagul Fibrinolysis | 1995 Jul |
1 |
11 | 8645525 | [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family]. | Ann Ital Med Int | 1996 Jan-Mar |
1 |
12 | 8745708 | [Retinal vein occlusion and resistance to activated protein C]. | J Fr Ophtalmol | 1995 |
2 |
13 | 8819251 | Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system. | Thromb Haemost | 1996 Jul |
1 |
14 | 8902986 | A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects. | Thromb Haemost | 1996 Oct |
1 |
15 | 9149031 | Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. | Cancer | 1997 May 15 |
2 |
16 | 9289995 | [Physical features of high-frequency artificial ventilation of lungs]. | Anesteziol Reanimatol | 1997 May-Jun |
1 |
17 | 9432898 | [The problem of airtightness during the use of a laryngeal mask under conditions of carboperitoneum and muscle relaxation]. | Anesteziol Reanimatol | 1997 Sep-Oct |
1 |
18 | 9693433 | [Effects of ventilation of the lungs in prone position on the pulmonary oxygenation function and hemodynamic parameters of heart surgery patients with respiratory insufficiency in the postoperative period]. | Anesteziol Reanimatol | 1998 May-Jun |
1 |
19 | 9716141 | Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting. | Thromb Haemost | 1998 Aug |
1 |
20 | 9855272 | Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden). | J Clin Gastroenterol | 1998 Dec |
1 |
21 | 10097286 | Mechanisms that regulate the anticoagulant function of coagulation factor V. | Scand J Clin Lab Invest Suppl | 1999 |
4 |
22 | 10402408 | The factor V Leiden mutation in Japanese couples with recurrent spontaneous abortion. | Hum Reprod | 1999 Jul |
1 |
23 | 10521265 | Partial glycosylation of Asn2181 in human factor V as a cause of molecular and functional heterogeneity. Modulation of glycosylation efficiency by mutagenesis of the consensus sequence for N-linked glycosylation. | Biochemistry | 1999 Oct 12 |
1 |
24 | 10598348 | [Resistance to activated protein C and pregnancy: thromboprophylaxis with low molecular weight heparin]. | J Gynecol Obstet Biol Reprod (Paris) | 1999 Oct |
2 |
25 | 10636214 | The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis. | J Clin Gastroenterol | 2000 Jan |
1 |
26 | 10926882 | Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. | Clin Chem | 2000 Aug |
1 |
27 | 10928623 | Detection of factor V Leiden in Thai patients with venous thrombosis. | Asian Pac J Allergy Immunol | 2000 Jun |
1 |
28 | 11586621 | [Brain protection in open heart surgery in patients with infective endocarditis]. | Anesteziol Reanimatol | 2001 Jul-Aug |
1 |
29 | 11593787 | [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A]. | Ned Tijdschr Geneeskd | 2001 Sep 22 |
2 |
30 | 11683790 | Warfarin-induced skin necrosis associated with Factor V Leiden and protein S deficiency. | Clin Lab Haematol | 2001 Aug |
1 |
31 | 11733730 | [Evaluation of resistance to activated protein C in myocardial infarction patients]. | Minerva Cardioangiol | 2001 Dec |
2 |
32 | 11760675 | [Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations]. | Arch Pediatr | 2001 Nov |
1 |
33 | 11914653 | A matrix-assisted laser desorption/ionization time-of-flight based method for screening the 1691G --> A mutation in the factor V gene. | Blood Coagul Fibrinolysis | 2002 Mar |
1 |
34 | 15135449 | Four-color multiplex 5' nuclease assay for the simultaneous detection of the factor V Leiden and the prothrombin G20210A mutations. | Mol Cell Probes | 2004 Jun |
1 |
35 | 15199491 | Congenital and acquired activated protein C resistance. | Semin Vasc Med | 2003 Feb |
2 |
36 | 15374562 | Epidural blood patch in a patient taking enoxaparin. | J Clin Anesth | 2004 Aug |
1 |
37 | 16045879 | [Benign intracranial hypertension and heterozygosity for factor V Leiden mutation]. | An Pediatr (Barc) | 2005 Aug |
1 |
38 | 16450127 | Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. | Ann Hematol | 2006 Apr |
1 |
39 | 16471711 | Intramolecular electron transfer in cofacially pi-stacked fluorenes: evidence of tunneling. | J Phys Chem B | 2006 Feb 2 |
2 |
40 | 16818854 | Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial. | J Natl Cancer Inst | 2006 Jul 5 |
2 |
41 | 17146542 | [Stroke: epidemiology, risk factors, and genetics]. | Hamostaseologie | 2006 Nov |
1 |
42 | 17200768 | No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study. | Thromb Haemost | 2007 Jan |
1 |
43 | 17269939 | Molecular characterization and subcellular localization of Tyr478del: a pathogenic in-frame deletion in coagulation factor V. | J Thromb Haemost | 2007 Feb |
1 |
44 | 17390701 | In situ-formed asymmetric membrane capsule for osmotic release of poorly water-soluble drug. | PDA J Pharm Sci Technol | 2007 Jan-Feb |
2 |
45 | 17721328 | CYP2C9 and VKORC1 genetic polymorphism analysis might be necessary in patients with Factor V Leiden and prothrombin gene G2021A mutation(s). | Diagn Mol Pathol | 2007 Sep |
1 |
46 | 18217158 | Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study. | Thromb Haemost | 2008 Jan |
1 |
47 | 18290319 | Separation of Factor V Leiden molecule, a mutated form of Factor V, from plasma of homozygous patient. | Adv Exp Med Biol | 2008 |
3 |
48 | 18641556 | Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period. | Ther Drug Monit | 2008 Aug |
1 |
49 | 18948369 | Prediction of recurrent venous thromboembolism by endogenous thrombin potential and D-dimer. | Clin Chem | 2008 Dec |
1 |
50 | 19003790 | Multimodal architectonic subdivision of the rostral part (area F5) of the macaque ventral premotor cortex. | J Comp Neurol | 2009 Jan 10 |
1 |